brca5 | 59566
Genetics Breast cancer
Keywords
BRCA1, BRCA2, breast cancer, CDH1, HBOC, Hereditary cancer, PALB2, PTEN, STK11, TP53
| Material |
|
|
| Note |
Screening for mutations and gene dosage changes in the genes BRCA1, BRCA2, PALB2, PTEN, STK11, TP53, CDH1. | Declaration of consent for genetic examination in accordance with GUMG required (see OF Human genetics or www.viollier.ch/en/SGMG_consent) | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. |
|
| Min. quantity | 4 mL | |
| Stability | 1 week / 2-8°C | |
| Duration | 3 weeks | |
| Frequency | 1 x per month | |
| Method | Next Generation Sequencing | |
| Price | CHF 3’294.90 | |
| Tariff | 3'294.90 TP |
Team of consultants
|
PhD
Christoph Noppen
FAMH Specialist in laboratory medicine, medical genetics
|
FAMH Specialist in laboratory medicine, medical genetics | T |
|
|
DSc
Henriette Kurth
FAMH Specialist in laboratory medicine, medical genetics
|
FAMH Specialist in laboratory medicine, medical genetics | T |
|
|
Dr. sc. nat.
Andrea Salzmann
Candidate FAMH Specialist in laboratory medicine, main field medical genetics
|
Candidate FAMH Specialist in laboratory medicine, main field medical genetics | T |
|